Bioequivalence Study of Patches With Different Equilibration Profiles

NCT00775086 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

42

Enrollment

INDUSTRY

Sponsor class

Conditions

Female Contraception

Interventions

DRUG: norelgestromin/ethinyl estradiol (NGMN/EE) transdermal contraceptive system.

Sponsor

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.